Comerica Bank Has Raised By $534,240 Its Novo Nordisk A S Adr (NVO) Position; Natures Sunshine Products Has 1 Sentiment

August 7, 2017 - By Darrin Black

Nature’s Sunshine Products, Inc. , together with its subsidiaries, is a natural health and wellness company. The company has market cap of $228.44 million. The Firm is engaged in the manufacturing and direct selling of nutritional and personal care products. It has a 111.31 P/E ratio. The Firm has four business divisions that are divided based on the various characteristics of their distributor bases, selling and distributor compensation plans, and product formulations, as well as the internal organization and business operations.

Comerica Bank increased Novo Nordisk A S Adr (NVO) stake by 8.57% reported in 2016Q4 SEC filing. Comerica Bank acquired 15,264 shares as Novo Nordisk A S Adr (NVO)’s stock rose 15.20%. The Comerica Bank holds 193,281 shares with $6.91M value, up from 178,017 last quarter. Novo Nordisk A S Adr now has $82.02B valuation. The stock declined 0.78% or $0.33 reaching $41.73 on the news. About 231,645 shares traded. Novo Nordisk A S (ADR) (NYSE:NVO) has declined 23.93% since August 7, 2016 and is downtrending. It has underperformed by 40.63% the S&P500.

Comerica Bank decreased Target Corp (NYSE:TGT) stake by 11,061 shares to 520,883 valued at $36.56 million in 2016Q4. It also reduced Powershares Db Commodity Index T (DBC) stake by 41,038 shares and now owns 137,558 shares. Las Vegas Sands Corp (NYSE:LVS) was reduced too.

Among 13 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 4 have Buy rating, 1 Sell and 8 Hold. Therefore 31% are positive. Novo Nordisk (ADR) had 14 analyst reports since August 28, 2015 according to SRatingsIntel. As per Friday, August 28, the company rating was initiated by Leerink Swann. The firm earned “Strong Buy” rating on Monday, October 19 by Jyske Bank. The stock has “Hold” rating by HSBC on Wednesday, August 31. UBS upgraded the stock to “Buy” rating in Tuesday, December 6 report. JP Morgan downgraded the stock to “Neutral” rating in Friday, September 9 report. The rating was upgraded by BNP Paribas on Tuesday, September 13 to “Outperform”. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Thursday, September 1 report. The company was downgraded on Monday, October 31 by DNB Markets. The stock of Novo Nordisk A S (ADR) (NYSE:NVO) earned “Hold” rating by Zacks on Friday, August 28. Goldman Sachs upgraded the stock to “Conviction Buy” rating in Monday, February 15 report.

Since January 1, 0001, it had 2 insider buys, and 1 insider sale for $187,821 activity.

About 5,288 shares traded. Nature’s Sunshine Prod. (NATR) has risen 25.56% since August 7, 2016 and is uptrending. It has outperformed by 8.86% the S&P500.